Side-by-side comparison of AI visibility scores, market position, and capabilities
Midland MI materials science (NYSE: DOW) ~$44.6B FY2024 revenue; world's largest polyethylene producer, Path2Zero net-zero ethylene Alberta, DowDuPont spinoff 2019, competing with LyondellBasell and BASF.
Dow Inc. is a Midland, Michigan-based global materials science company — publicly traded on the New York Stock Exchange (NYSE: DOW) as a Dow Jones Industrial Average and S&P 500 Materials component — producing performance materials and coatings (epoxy resins, acrylics, polyurethane systems), industrial intermediates and infrastructure (ethylene oxide, propylene glycol, polyurethanes), and packaging and specialty plastics (polyethylene resins for flexible packaging, agricultural films, and wire/cable jacketing) through approximately 35,000 employees in 31 countries. Dow Inc. was spun off from DowDuPont in April 2019 — one segment of the three-way DowDuPont breakup (Dow materials science, DuPont specialty products, Corteva agriculture) — concentrating Dow on commodity and specialty chemicals where scale and feedstock integration create structural cost advantages over less-integrated competitors. In fiscal year 2024, Dow reported revenues of approximately $44.6 billion, with adjusted EBITDA of approximately $5.4 billion — reflecting the materials science cycle's pressure from elevated natural gas and naphtha feedstock costs (European gas prices remaining elevated versus pre-2022 levels), weak downstream demand in construction (polyurethane insulation), automotive (coatings and sealants), and consumer packaging (flexible films). CEO Jim Fitterling leads Dow's strategic transformation toward circularity and carbon neutralization: the Path2Zero program (building the world's first net-zero integrated ethylene cracker in Alberta, Canada — Fort Saskatchewan Decarbonization project — converting existing ethylene production to hydrogen-fired crackers and carbon capture by 2030) positions Dow for the premium pricing that brand owners (Unilever, P&G, Nestlé) will pay for demonstrated low-carbon polyethylene resin to meet their Scope 3 emissions commitments.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.